Trending Articles

  1. MilliporeSigma to acquire JSR Life Sciences’ chromatography business, boosting Protein A purification capabilities The acquisition expands MilliporeSigma’s downstream bioprocessing portfolio with JSR’s Amsphere Protein A resin technology, enhancing efficiency and reliability in...
  2. Kailera Therapeutics secures $600m in Series B financing to advance next-generation obesity therapies The funding will support the advancement of Kailera’s obesity portfolio, including a global Phase III clinical programme of Kailera’s lead candidate KAI-9531, an injectable...
  3. MoonLake Immunotherapeutics faces Securities Class Action after disastrous Phase III trial results The announcement about the trial results for the product candidate sonelokimab, a highly anticipated treatment for patients with skin disease, saw MoonLake investors' shares...
  4. LTS expands CDMO footprint with acquisition of Renaissance Lakewood LTS Lohmann Therapie-Systeme has agreed to acquire US-based CDMO Renaissance Lakewood, strengthening its position in nasal spray and sterile dosage form manufacturing and...
  5. Nanoform collaborates with A.forall and IMGA to outlicence Nanoencorafenib Nanoform will establish a new company, BRAFMed, to progress the clinical development and future outlicensing of the patient-centric nanoformulation of encorafenib

Upcoming event

CPHI Frankfurt 2025

28–30 October 2025 | Exhibition | Frankfurt, Germany See all

You may also like

Finance The Spanish agarose resin specialist will expand into the US and India, invest in scalable bioprocessing technologies and enhance sustainability across its European facilities...

Agarose Bead Technologies marks 25 years with $10m global expansion plan

Read more
Packaging The investment will boost sterile fill/finish, injectable packaging and oral solid dose capacity across Sharp's US and European sites, strengthening its clinical and commercial...

Sharp Services invests $100m to expand global sterile and packaging capacity across US and Europe

Read more
Finance The acquisition expands MilliporeSigma’s downstream bioprocessing portfolio with JSR’s Amsphere Protein A resin technology, enhancing efficiency and reliability in...

MilliporeSigma to acquire JSR Life Sciences’ chromatography business, boosting Protein A purification capabilities

Read more
Finance The CDMO's partnership with Curewell will provide significant growth capital to expand WPT’s manufacturing capacity and further scale its end-to-end capabilities in producing...

Wilmington PharmaTech secures further funding for its expansion from Curewell Capital

Read more
Regulatory The announcement about the trial results for the product candidate sonelokimab, a highly anticipated treatment for patients with skin disease, saw MoonLake investors' shares...

MoonLake Immunotherapeutics faces Securities Class Action after disastrous Phase III trial results

Read more
Finance The agreement grants Novo Nordisk exclusive global rights to develop and commercialise the clinical-stage antibody for rare blood and kidney disorders, strengthening its Rare...

Novo Nordisk acquires rights to Omeros’ MASP-3 inhibitor zaltenibart in $2.1bn deal

Read more
Finance The funding will support the advancement of Kailera’s obesity portfolio, including a global Phase III clinical programme of Kailera’s lead candidate KAI-9531, an injectable...

Kailera Therapeutics secures $600m in Series B financing to advance next-generation obesity therapies

Read more
Finance LTS Lohmann Therapie-Systeme has agreed to acquire US-based CDMO Renaissance Lakewood, strengthening its position in nasal spray and sterile dosage form manufacturing and...

LTS expands CDMO footprint with acquisition of Renaissance Lakewood

Read more
Finance Nanoform will establish a new company, BRAFMed, to progress the clinical development and future outlicensing of the patient-centric nanoformulation of encorafenib

Nanoform collaborates with A.forall and IMGA to outlicence Nanoencorafenib

Read more
Manufacturing Transformation program launched to boost performance and free cash flow

Gerresheimer adjusts 2025 guidance amid slower market growth

Read more
Manufacturing AstraZeneca has reached an agreement with the Trump administration to lower medicine costs, pledging $50bn in US manufacturing and R&D investment, whilst safeguarding the...

AstraZeneca strikes deal with US government to cut drug prices and boost domestic manufacturing

Read more
Finance Bristol Myers Squibb will acquire Orbital Therapeutics in a $1.5bn deal, adding next-generation RNA-based in vivo CAR T technology to its cell therapy pipeline and expanding...

Bristol Myers Squibb strengthens and diversifies cell therapy portfolio with acquisition of Orbital Therapeutics

Read more
Manufacturing AstraZeneca will develop a state-of-the-art manufacturing facility in Albemarle County, Virginia, producing a broader range of medicines, including weight management, metabolic...

AstraZeneca to expand Virginia manufacturing facility with $4.5bn investment, creating 3600 jobs

Read more
Finance Axplora is investing more than €100m across its global network in 2025, with major projects in France, Italy and India aimed at strengthening small molecule API production...

Axplora announces €100m global investment drive to expand API and ADC manufacturing capacity

Read more
Finance The breath and urine tests are part of the POSEIDON programme, which aims to enable accurate, low-cost, accessible cancer screening for all Americans

Owlstone Medical wins up to $49.1m award to develop at-home cancer detection tests

Read more
Finance The funding will help fast-track clinical trials for treatments addressing dry age-related macular degeneration and severe acute hepatitis, supporting the company’s...

SeaBeLife raises €2 million to advance dual-target cell death therapies

Read more